Repligen Corp (RGEN.OQ)
RGEN.OQ on NASDAQ Stock Exchange Global Select Market
37.44USD
19 Apr 2018
37.44USD
19 Apr 2018
Change (% chg)
$-1.09 (-2.83%)
$-1.09 (-2.83%)
Prev Close
$38.53
$38.53
Open
$38.33
$38.33
Day's High
$38.71
$38.71
Day's Low
$37.32
$37.32
Volume
67,669
67,669
Avg. Vol
112,137
112,137
52-wk High
$46.81
$46.81
52-wk Low
$29.58
$29.58
About
Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It... (more)
Overall
| Beta: | 1.07 |
| Market Cap(Mil.): | $1,667.74 |
| Shares Outstanding(Mil.): | 43.51 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| RGEN.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 75.20 | 30.95 | 32.74 |
| EPS (TTM): | 0.51 | -- | -- |
| ROI: | 6.40 | 14.84 | 14.38 |
| ROE: | 9.98 | 16.34 | 16.07 |
BRIEF-Repligen Reports Q4 GAAP Earnings Per Share $0.27
* REPLIGEN REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS, PROVIDES GUIDANCE FOR 2018
BRIEF-Repligen reports Q3 adjusted non-GAAP earnings per share $0.15
* Q3 earnings per share view $0.11 -- Thomson Reuters I/B/E/S
BRIEF-Repligen extends long term supply agreement with Purolite for Protein A ligands
* Repligen extends long term supply agreement with Purolite for Protein A ligands
Competitors
| Price | Chg | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $127.55 | -0.17 |
| Novartis AG (NOVN.S) | CHF77.28 | -- |
| Roche Holding Ltd. (ROG.S) | CHF216.50 | -- |
| Roche Holding Ltd. (RO.S) | CHF220.20 | -- |
| Merck & Co., Inc. (MRK.N) | $58.64 | -0.28 |
| Sanofi SA (SASY.PA) | €65.60 | -- |
| Amgen, Inc. (AMGN.OQ) | $172.93 | -2.18 |
| Gilead Sciences, Inc. (GILD.OQ) | $74.44 | -1.24 |
| Incyte Corporation (INCY.OQ) | $69.05 | -1.02 |
Estimates